Hot Pursuit     15-Feb-24
Natco Pharma Ltd soars 1.38%
Natco Pharma Ltd is quoting at Rs 897, up 1.38% on the day as on 12:49 IST on the NSE. The stock is up 66.81% in last one year as compared to a 21.22% spurt in NIFTY and a 51.05% spurt in the Nifty Pharma index.

Natco Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 897, up 1.38% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 21863.25. The Sensex is at 71855.64, up 0.05%. Natco Pharma Ltd has risen around 7.83% in last one month.

Meanwhile, Nifty Pharma index of which Natco Pharma Ltd is a constituent, has risen around 7.25% in last one month and is currently quoting at 18584.35, down 0.04% on the day. The volume in the stock stood at 9.78 lakh shares today, compared to the daily average of 5.59 lakh shares in last one month.

The PE of the stock is 14.98 based on TTM earnings ending September 23.

Previous News
  Natco Pharma consolidated net profit rises 83.55% in the September 2024 quarter
 ( Results - Announcements 12-Nov-24   17:16 )
  Indices turn rangebound; metal shares slide; VIX rises 3.93%
 ( Market Commentary - Mid-Session 04-Sep-24   12:36 )
  Natco Pharma
 ( Results - Analysis 13-Feb-25   11:41 )
  Natco Pharma fixes record date for 3rd interim dividend
 ( Market Beat - Reports 14-Feb-24   15:11 )
  Board of Natco Pharma recommends second interim dividend
 ( Corporate News - 12-Nov-24   17:01 )
  Board of Natco Pharma recommends Third Interim Dividend
 ( Corporate News - 12-Feb-25   16:43 )
  Volumes spurt at Syngene International Ltd counter
 ( Hot Pursuit - 24-Apr-25   14:30 )
  Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
 ( Corporate News - 04-Sep-24   12:07 )
  Natco Pharma
 ( Results - Analysis 15-Nov-23   14:30 )
  Natco Pharma Ltd soars 3.1%, gains for fifth straight session
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Board of Natco Pharma recommends Second Interim Dividend
 ( Corporate News - 16-Nov-23   09:39 )
Other Stories
  Wendt (India) tanks as foreign promoter plans exit via OFS
  15-May-25   17:12
  Alembic Pharma rises on USFDA approval for Rivaroxaban Tablets
  15-May-25   16:36
  SSWL declines as Q4 PAT tumbles 88% YoY to Rs 61 cr
  15-May-25   15:44
  Saregama India gains after Q4 PAT climbs 12% YoY to Rs 60 cr
  15-May-25   15:29
  Apar Inds rises over 15% in two days on strong Q4 results
  15-May-25   15:27
  Cochin Shipyard spurts as Q4 PAT jumps 11% YoY to Rs 287 crore
  15-May-25   15:10
  Muthoot Finance Ltd leads losers in 'A' group
  15-May-25   15:00
  Persistent Systems tumbles as key US client faces criminal probe
  15-May-25   14:48
  Wendt India Ltd leads losers in 'B' group
  15-May-25   14:45
  ITC Hotels registers 20% YoY increase in Q4 PAT
  15-May-25   14:42
Back Top